Masimo Corp. (MASI) Tops Q3 EPS by 9c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Masimo Reports Third Quarter 2022 Financial Results
November 8, 2022 4:05 PM ESTThird Quarter 2022 Highlights
Consolidated revenue was $549 million; Healthcare revenue was $327 million, representing 6% reported growth and 10% constant currency growth; and Non-healthcare revenue was $222 million.IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (Nasdaq: MASI) today announced its financial results for the third quarter of 2022, ended October 1, 2022.
Third Quarter 2022 Financial Results
Consolidated revenue was $549.3 million, representing 78.7% reported growth compared to $307.4 million in the third quarter of 2021. Healthcare revenue was $327.2 million, which represents 6.4% reported growth and 10.0% growth on a constant currency basis. Non-healthcare revenue was $222.1... More
